Study of a new heart device for atrial fibrillation patients
Part of Heart & circulation clinical trials.
This trial tests a new device called LAmbre™ II that closes off a part of the heart called the left atrial appendage to help prevent strokes in people with atrial fibrillation who cannot take blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have atrial fibrillation that comes and goes, stays all the time, or is long-lasting, but not caused by heart valve problems.
- Your stroke risk score is 2 or higher for men or 3 or higher for women.
- You have a reason to avoid blood thinners, like side effects or other risks.
- You agree to take required medicines and come for follow-up visits after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device (AnchorMan®) that closes a small pouch in the heart to prevent strokes in people with atrial fibrillation. It is for patients who have a high stroke risk but cannot take blood thinners long-term.
This trial tests a device called LAmbre™ II that is placed in the heart to reduce stroke risk in people with atrial fibrillation who cannot take blood thinners. It may be an option if you need an alternative to long-term blood-thinning medication.
This trial tests a new device (LAmbre Plus) that closes off a small pouch in the heart (left atrial appendage) to reduce stroke risk in people with AFib who cannot take blood thinners long-term. The procedure is an alternative to daily medication.
This study compares two devices (LAmbre and AMPLATZER Amulet) that are placed in the heart to prevent strokes in people with atrial fibrillation who cannot take blood thinners. If you join, you will be randomly assigned to get one of the two devices.
This trial compares two different devices (Amplatzer Amulet and LAmbre) used to close a small pouch in the heart called the left atrial appendage. People with atrial fibrillation who are at high risk for stroke and bleeding may be able to stop blood thinners after the procedure.
This study is testing a device called LAMBRE that is used to close a small pocket in the heart (the left atrial appendage). The goal is to see how well it works in everyday medical practice for people who need this closure procedure.
Hear when a new Non-valvular Atrial Fibrillation (NVAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.